Resolute Oncology (Update Pharma) updatepharma.com

Resolute Oncology, formerly Update Pharma, is developing UPI-928, an agent developed in the 1980's by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemia, lymphoma breast and ovarian cancers and a marketing approval in France for the treatment of acute myeloid leukemia (AML)...Show all

Resolute Oncology, formerly Update Pharma, is developing UPI-928, an agent developed in the 1980's by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable sa...Show all

See All Exits Recent Exits

Phone:

Fax:



New York,
New York, United States

Resolute Oncology (Update Pharma) - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2013-09-09Resolute OncologyMerger
See all 1 investments